IGM Biosciences Announces Worldwide Collaboration Agreement With Sanofi To Create And Develop IgM Agonist Antibodies Will Focus Exclusively On Immunology/Inflammation Targets
IGM Biosciences宣佈與賽諾菲簽訂全球合作協議,以創建和開發IgM激動劑抗體將專注於免疫學/炎症靶標
IGM Biosciences Announces Worldwide Collaboration Agreement With Sanofi To Create And Develop IgM Agonist Antibodies Will Focus Exclusively On Immunology/Inflammation Targets
IGM Biosciences宣佈與賽諾菲簽訂全球合作協議,以創建和開發IgM激動劑抗體將專注於免疫學/炎症靶標
使用瀏覽器的分享功能,分享給你的好友吧